Antonio Antón-Torres

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

Enrique Aranda, Eduardo Díaz‐Rubio, Andrés Cervantes et al. · Annals of Oncology · 1998 · 96 citations · Full text

Medicine, Oncology, Pharmacology +14

High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer

Emilio Alba, Aňa Lluch, Nuria Ribelles et al. · The Oncologist · 2016 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +17

Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial

Víctor Moreno, Maria-Pilar Barretina-Ginesta, Jesús García-Donás et al. · Journal for ImmunoTherapy of Cancer · 2021 · 54 citations · Full text

Medicine, Oncology, Pharmacology +16

Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial

Enrique Aranda, I. Barneto, Andrés Cervantes et al. · Annals of Oncology · 1996 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Judith Balmañà, Peter A. Fasching, Fergus J. Couch et al. · Breast Cancer Research and Treatment · 2023 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17